|
Q3 FY2019
As of Dec 31, 2018
|
Q2 FY2019
As of Sep 30, 2018
|
Q1 FY2019
As of Jun 30, 2018
|
Q4 FY2018
As of Mar 31, 2018
|
Q3 FY2018
As of Dec 31, 2017
|
Q2 FY2018
As of Sep 30, 2017
|
Q1 FY2018
As of Jun 30, 2017
|
Q4 FY2017
As of Mar 31, 2017
|
Q3 FY2017
As of Dec 31, 2016
|
Q2 FY2017
As of Sep 30, 2016
|
Q1 FY2017
As of Jun 30, 2016
|
Q4 FY2016
As of Mar 31, 2016
|
Q1 FY2016
As of Jun 30, 2015
|
Q4 FY2015
As of Mar 31, 2015
|
Q3 FY2015
As of Dec 31, 2014
|
Q2 FY2015
As of Sep 30, 2014
|
Q1 FY2015
As of Jun 30, 2014
|
Q4 FY2014
As of Mar 31, 2014
|
Q3 FY2014
As of Dec 31, 2013
|
Q2 FY2014
As of Sep 30, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIENCY | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Accrued technology access fee | ||||||||||||||||||||
| Secured convertible debentures | ||||||||||||||||||||
| Due to officers | ||||||||||||||||||||
| Convertible debt-related party | ||||||||||||||||||||
| Notes payable related party | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Common stock, $0.001 par value; 250,000,000 shares authorized, 96.6 million and 51.9 million shares issued and outstanding as of December 31, 2018 and March 31, 2018, respectively | ||||||||||||||||||||
| Stock subscriptions | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders' Equity (Deficit) | ||||||||||||||||||||
| Total Stockholders' Deficiency | ||||||||||||||||||||
| Total Liabilities and Stockholders' Deficiency | ||||||||||||||||||||
Loading...
